on Affluent Medical (isin : FR0013333077)
Carvolix Strengthens Its Leadership Team
Carvolix, a French medical technology company, formerly known as Affluent Medical, has announced strategic changes to its leadership team. Anne Lange joins the Board of Directors, replacing Soad El Gazaoui. Lange brings extensive experience in innovation and digital transformation.
Additionally, Rute Fernandes has been appointed as a Board Observer, adding significant expertise in global commercial operations and rare diseases.
The company further enhances its advisory capabilities with the appointments of Paul LaViolette and Dr. Mirvat Alasnag to its advisory board, reinforcing Carvolix's scientific and clinical leadership.
Carvolix's governance structure now includes Liane Teplitsky as the Chair and Michel Therin as Vice Chair, strengthening its leadership team to support ambitious business goals. The company is recognized for its advancements in AI-driven mini-robots and biomimetic implants.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Affluent Medical news